Ralliant Corporation (NYSE:RAL) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Ralliant Corporation (NYSE:RAL) have been assigned an average recommendation of “Moderate Buy” from the twelve research firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, seven have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $75.70.

Several research analysts recently weighed in on the company. TD Cowen boosted their target price on Ralliant from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Evercore started coverage on Ralliant in a research note on Tuesday, June 9th. They issued an “outperform” rating and a $80.00 price target for the company. Wall Street Zen upgraded Ralliant from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Morgan Stanley upped their price objective on shares of Ralliant from $68.00 to $85.00 and gave the company an “overweight” rating in a report on Tuesday, June 23rd. Finally, Zacks Research raised shares of Ralliant from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th.

Ralliant Price Performance

Shares of RAL opened at $61.87 on Wednesday. The company has a 50 day moving average of $68.69 and a two-hundred day moving average of $56.04. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.75. Ralliant has a twelve month low of $37.27 and a twelve month high of $75.41. The company has a market cap of $6.85 billion, a price-to-earnings ratio of -5.70, a price-to-earnings-growth ratio of 2.34 and a beta of 1.60.

Ralliant (NYSE:RAL) last issued its quarterly earnings results on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.63 by $0.05. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.The business had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, analysts predict that Ralliant will post 2.87 earnings per share for the current fiscal year.

Ralliant Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s dividend payout ratio is presently -1.84%.

Insiders Place Their Bets

In other news, CEO Tamara S. Newcombe sold 12,936 shares of Ralliant stock in a transaction on Friday, August 14th. The shares were sold at an average price of $71.79, for a total transaction of $928,675.44. Following the completion of the sale, the chief executive officer directly owned 251,967 shares in the company, valued at approximately $18,088,710.93. The trade was a 4.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of Ralliant stock in a transaction on Monday, August 17th. The stock was sold at an average price of $72.00, for a total transaction of $436,464.00. Following the sale, the senior vice president owned 31,668 shares of the company’s stock, valued at $2,280,096. The trade was a 16.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.42% of the company’s stock.

Institutional Trading of Ralliant

Several large investors have recently added to or reduced their stakes in RAL. Dunhill Financial LLC acquired a new stake in shares of Ralliant during the second quarter worth about $25,000. Global Retirement Partners LLC acquired a new position in Ralliant in the 2nd quarter worth approximately $35,000. Group One Trading LLC purchased a new position in Ralliant during the 2nd quarter worth approximately $36,000. Danske Bank A S purchased a new position in Ralliant during the 4th quarter worth approximately $25,000. Finally, Persistent Asset Partners Ltd acquired a new stake in Ralliant during the 2nd quarter valued at approximately $37,000.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.